All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Comparison of two long-term gestagen regimens in the management of recurrent vulvovaginal candidiasis: A pilot study

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F17%3A10366358" target="_blank" >RIV/00216208:11150/17:10366358 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11160/17:10366358 RIV/00179906:_____/17:10366358

  • Result on the web

    <a href="http://onlinelibrary.wiley.com/doi/10.1111/myc.12593" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/myc.12593</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/myc.12593" target="_blank" >10.1111/myc.12593</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Comparison of two long-term gestagen regimens in the management of recurrent vulvovaginal candidiasis: A pilot study

  • Original language description

    Vulvovaginal candidiasis (VVC) is a hormonal-dependent infection but in contrast to sporadic VVC, therapy of recurrent vulvovaginal candidiasis (RVVC) is still unsolved. Long-term administration of medroxyprogesterone acetate was evaluated for the management of RVVC. Overall, 20 patients were treated with Depo-Provera; 14 patients were treated with Provera. Gestagen therapy was evaluated based on visual analogue scale (VAS), the frequency of attacks, the side effects of gestagens and the consumption of antifungals. There was a reduced symptomatology in both of the groups and substantial reduction in antifungal drug consumption during the second year of gestagen use. Twenty-four patients (70.6%) evaluated their condition regarding the vulvovaginal area as improvement (VAS decrease of 3-5 points). Five patients (14.7%) mentioned minimal or no improvement. Further, a number of antifungal drug-treated episodes dropped dramatically during the study period. Both regimes provided similar results, but five patients from the Depo-Provera group had to withdraw from gestagen therapy. Gestagen supplementation ameliorated the quality of life for the majority of patients with RVVC and suggested a potential role in the management of this syndrome, even if beneficial effect was evident after longer application, and some patients met with side effects that led to an interruption of therapy.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30216 - Dermatology and venereal diseases

Result continuities

  • Project

    <a href="/en/project/NV15-29225A" target="_blank" >NV15-29225A: Study of vaginal microbiota and its relationship to recurrent vulvovaginal discomfort</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Mycoses

  • ISSN

    0933-7407

  • e-ISSN

  • Volume of the periodical

    60

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    6

  • Pages from-to

    260-265

  • UT code for WoS article

    000395433700007

  • EID of the result in the Scopus database

    2-s2.0-85014511198